The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change

By  

ALLERGY, Vol. 73, Iss. 3, 2018-03 ,pp. : 705-712

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: case series

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 26, Iss. 6, 2015-09 ,pp. : 585-588

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical evaluation of a diagnostic strategy for deep venous thrombosis with exclusion by low plasma levels of fibrin degradation product D-dimer

By Lindahl T L   Lundahl T H   Ranby M   Fransson S-G  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 58, Iss. 4, 1998-09 ,pp. : 307-316

Informa Healthcare

Access to resources Recommend Favorite

Thrombin-antithrombin III and D-dimer plasma levels in patients with benign or malignant ovarian tumours

By den Ouden M   Ubachs J M H   Stoot J E G M   van Wersch J W J  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 58, Iss. 7, 1998-12 ,pp. : 555-560

Informa Healthcare

Access to resources Recommend Favorite

Does omalizumab modify a course of recalcitrant chronic spontaneous urticaria?: A retrospective study in Asian patients

By  

THE JOURNAL OF DERMATOLOGY, Vol. 45, Iss. 1, 2018-01 ,pp. : 17-23

John Wiley & Sons Inc

Access to resources Recommend Favorite